The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 23, 2021

Filed:

Oct. 25, 2018
Applicant:

Critical Care Diagnostics, Inc., San Diego, CA (US);

Inventors:

James V. Snider, San Diego, CA (US);

Robert W. Gerwien, Newington, CT (US);

Assignee:

Critical Care Diagnostics, Inc., San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/68 (2006.01); A61P 9/04 (2006.01); G01N 33/566 (2006.01); C07K 14/705 (2006.01); C07K 14/715 (2006.01); C07K 14/54 (2006.01); C07K 16/24 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
G01N 33/566 (2013.01); A61P 9/04 (2018.01); G01N 33/53 (2013.01); G01N 33/6869 (2013.01); G01N 33/6893 (2013.01); C07K 14/54 (2013.01); C07K 14/7155 (2013.01); C07K 16/2866 (2013.01); G01N 2333/7155 (2013.01); G01N 2800/32 (2013.01); G01N 2800/52 (2013.01);
Abstract

Methods of treating a subject having a cardiovascular disease, selecting a therapy for a subject having a cardiovascular disease, identifying a subject having a cardiovascular disease that will benefit or not benefit from exercise therapy, determining whether a subject having a cardiovascular disease should begin, continue, not begin, discontinue, or avoid exercise therapy, determining whether a subject having a cardiovascular disease should continue, discontinue, or avoid exercise therapy, reducing the risk of an adverse outcome (e.g., death) in a subject having a cardiovascular disease, and predicting the efficacy of exercise therapy in a subject having a cardiovascular disease. These methods include determining a level of soluble ST2 in a subject.


Find Patent Forward Citations

Loading…